Publications by authors named "Janice Lu"

Claim this Profile
M
Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event Reporting.
Neel D Pasricha, Stella K Kim, Asim V Farooq, Ethan S Lindgren, Rongshan Yan, Lucia Sobrin, Janice Lu

JAMA Ophthalmol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis.
David Scholten, Lamiaa El-Shennawy, Yuzhi Jia, Youbin Zhang, Elizabeth Hyun, Janice Lu

J Clin Invest· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Biopsy Approaches for Cancer Characterization, Residual Disease Detection, and Therapy Monitoring.
Jacqueline V Aredo, Amna Jamali, Jessica Zhu, Natalie Heater, Heather A Wakelee, Janice Lu

Am Soc Clin Oncol Educ Book· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare Subset of T Cells Form Heterotypic Clusters with Circulating Tumor Cells to Foster Cancer Metastasis.
David Scholten, Lamiaa El-Shennawy, Yuzhi Jia, Youbin Zhang, Elizabeth Hyun, Janice Lu

bioRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future immunotherapy for breast cancer.
Natalie K Heater, Surbhi Warrior, Janice Lu

J Hematol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elacestrant in ER+, HER2- Metastatic Breast Cancer with ESR1-Mutated Tumors: Subgroup Analyses from the Phase III EMERALD Trial by Prior Duration of Endocrine Therapy plus CDK4/6 Inhibitor and in Clinical Subgroups.
Aditya Bardia, Javier Cortés, François-Clément Bidard, Patrick Neven, José Garcia-Sáenz, Janice Lu

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22-mediated lipolysis circuit.
Yuanzhang Zhou, Peng Chu, Ya Wang, Na Li, Qiong Gao, Janice Lu

Sci Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Mitigation of Corneal Pseudomicrocysts Induced by Antibody-Drug Conjugates (ADCs).
Ethan S Lindgren, Rongshan Yan, Onur Cil, Alan S Verkman, Matilda F Chan, Janice Lu

Curr Ophthalmol Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Janice Lu

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Proteogenomic Analysis Reveals Distinct Potentially Actionable Therapeutic Vulnerabilities in Triple-Negative Breast Cancer Subtypes.
Pushpinder Kaur, Alexander Ring, Tania B Porras, Guang Zhou, Janice Lu

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.
Julie O Culver, Yael Freiberg, Charité Ricker, Jacob G Comeaux, Emmeline Y Chang, Janice Lu

Ann Surg Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions.
Priya Jayachandran, Francesca Battaglin, Carly Strelez, Annika Lenz, Sandra Algaze, Janice Lu

Oncogene· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial.
Marie Osdoit, Christina Yau, W Fraser Symmans, Judy C Boughey, Cheryl A Ewing, Oluwole Fadare, Janice Lu

JAMA Surg· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.
Francois-Clement Bidard, Virginia G Kaklamani, Patrick Neven, Guillermo Streich, Alberto J Montero, Janice Lu

J Clin Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer.
Sonia Maryam Setayesh, Olivia Hart, Amin Naghdloo, Nikki Higa, Jorge Nieva, Janice Lu

NPJ Breast Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
Alexander Ring, Daniel Campo, Tania B Porras, Pushpinder Kaur, Victoria A Forte, Janice Lu

Ann Surg Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
Alexander Ring, Daniel Campo, Tania B Porras, Pushpinder Kaur, Victoria A Forte, Janice Lu

Ann Surg Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer.
Cynthia X Ma, Jingqin Luo, Rachel A Freedman, Timothy J Pluard, Julie R Nangia, Janice Lu

Clin Cancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer at a safety net medical center.
Rachel E Sargent, Elizabeth Vazquez, Irene Kang, Janice Lu, Tejas Manchandia

Am J Surg· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib.
Stephanie N Shishido, Rahul Masson, Liya Xu, Lisa Welter, Rishvanth Kaliappan Prabakar, Janice Lu

NPJ Breast Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
Michelino De Laurentiis, Simona Borstnar, Mario Campone, Ellen Warner, Javier Salvador Bofill, Janice Lu

Breast Cancer Res Treat· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
Michelino De Laurentiis, Simona Borstnar, Mario Campone, Ellen Warner, Javier Salvador Bofill, Janice Lu

Breast Cancer Res Treat· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of putative actionable alterations in clinically relevant genes in breast cancer.
Pushpinder Kaur, Tania B Porras, Anthony Colombo, Alexander Ring, Janice Lu

Br J Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.

JAMA Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer.
Pushpinder Kaur, Daniel Campo, Tania B Porras, Alexander Ring, Janice Lu

Int J Mol Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis